To repeatedly dash the hopes of holders on the basis that the company is not-self sustaining knowing that Mesoblast is in a phase of seeking approval of their products and operating in a disruptive therapy environment either shows a lack of understanding or a motivated attempt to spook investors.
Knowing many holders have bought in a lot higher and to continue this practise on this forum also shows a level of insensitivity which is somewhat disgraceful.
MSB Price at posting:
$1.33 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)